Abdollahi-Aghdam Abdollah, Majidi Mir Reza, Veladi Hadi, Omidi Yadollah
Department of Analytical Chemistry, Faculty of Chemistry, University of Tabriz, Tabriz, Iran.
Research Center for Pharmaceutical Nanotechnology, Biomedicine Institute, Tabriz University of Medical Sciences, Tabriz, Iran.
Bioimpacts. 2021;11(4):263-269. doi: 10.34172/bi.2021.35. Epub 2020 Jan 10.
A new microfluidic-based method with electrochemical detection was developed for the simultaneous quantification of acetaminophen (AP) and phenylephrine (PHE) pharmaceuticals in the human blood and pharmaceuticals (e.g. tablet and drop). The separation was achieved on a SU8/glass microchip with a 100 µm Pt working electrode that was positioned out of the channel and 2-(N-morpholino) ethanesulfonic acid was used as a running buffer (pH 7, 10 mM). Home designed modulated high voltage power supply and dual time switcher was used for controlling the injection and separation of the analytes in the unpinched injection mode. The injection was carried out using +750 V for 7 seconds, and the separation and detection voltages were set at +1000 V and +0.9 V, respectively. Critical parameters such as detection potential, buffer concentration, injection, and separation voltage were studied in terms of their effects on the resolution, peak height, and migration times. For each analyte, the correlation coefficients were over 0.99 (n = 6). The developed microchip was able to detect AP and phenylephrine simultaneously with the limit of detection of 7.9 and 5.2 (µg/mL) respectively for PHE and AP and excellent linear range of 10-200 (µg/mL). The recovery of the drugs ranged from 96% to 103%, while the repeatability of the method through inter- and intra-day was lower than 7%. The developed method offers several advantages, including easy sample pretreatment process, simplicity, very fast analysis compared to other typical chromatographic methods. Thus, the proposed microfluidic-based method is proposed to be used as a time- and cost-effective monitoring method for the analysis of AP and PHE.
开发了一种基于微流控的电化学检测新方法,用于同时定量检测人血液和药物(如片剂和滴剂)中的对乙酰氨基酚(AP)和去氧肾上腺素(PHE)。在带有100 µm铂工作电极的SU8/玻璃微芯片上实现分离,该电极位于通道外部,使用2-(N-吗啉代)乙磺酸作为运行缓冲液(pH 7,10 mM)。采用自行设计的调制高压电源和双时间切换器,以非夹流进样模式控制分析物的进样和分离。使用+750 V进样7秒,分离和检测电压分别设置为+1000 V和+0.9 V。研究了检测电位、缓冲液浓度、进样和分离电压等关键参数对分离度、峰高和迁移时间的影响。每种分析物的相关系数均超过0.99(n = 6)。所开发的微芯片能够同时检测AP和去氧肾上腺素,对PHE和AP的检测限分别为7.9和5.2(µg/mL),线性范围为10 - 200(µg/mL),效果良好。药物回收率在96%至103%之间,该方法日间和日内的重复性低于7%。所开发的方法具有几个优点,包括样品预处理过程简单、操作简便,与其他典型色谱方法相比分析速度非常快。因此,所提出的基于微流控的方法被提议用作分析AP和PHE的一种省时且经济高效的监测方法。